Gynecologic oncology Clinical Trials in Wilmington, DE
As of June 2026, 2 paid clinical trials are recruiting for Gynecologic oncology in Wilmington, Delaware. Gynecologic oncology studies test PARP inhibitors, antibody-drug conjugates, maintenance therapies, and immune checkpoint inhibitors for ovarian, endometrial, cervical, and other gyn cancers. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
2 clinical trials for Gynecologic oncology
·Clear filters·↓ Download CSVA Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
About research studies in Wilmington
Wilmington has approximately 161 recruiting research studies across a wide range of therapeutic areas. Delaware hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Wilmington
Researchers run research studies in Wilmington, DE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Christiana Care Health System-Wilmington Hospital | Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 39 |
| Alfred I duPont Hospital for Children | Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 32 |
| Nemours Children's Hospital | Fracture Distal Radius, Abdominal Pain, Alport Syndrome | 10 |
| Nemours Children's Health | Anemia, Sickle Cell, Bone Marrow Failure Syndromes, Cardiac Arrest (CA) | 6 |
| Alfred I. DuPont Hospital for Children | Pain, Adrenal Insufficiency, Anesthesia | 4 |
| Nemours Alfred I. Dupont Hospital for Children | Achondroplasia, Acute Myeloid Leukemia, Cardiomyopathy | 4 |
| Nemours Children's Hospital, Delaware | Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation, Gastroschisis | 4 |
| Nemours Children's Health, Delaware | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 3 |
| Nemours/Alfred I. duPont Hospital for Children | Bone Cyst, Idiopathic Scoliosis, Osteogenesis Imperfecta (OI) | 3 |
| EndoVascular Consultants | Chronic Limb-Threatening Ischemia, Chronic Total Occlusion of Artery of the Extremities | 2 |
| Nemours | IMAGe Syndrome, LIG4 Syndrome, MOPDII | 2 |
| Nemours Children's Hospital - Delaware - Cardiology | Heart Failure (Pediatric), Left Ventricular Systolic Dysfunction | 2 |
| Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children) | Hypochondroplasia, Noonan Syndrome | 2 |
| Nemours/A.I. duPont Hospital for Children | Focal Segmental Glomerulosclerosis, Healthy Volunteers, Neuromuscular Diseases | 2 |
| AI Dupont Hospital for Children | Osteogenesis Imperfecta | 1 |
| Alfred I. DuPont Hospital for Children of the Nemours Foundation | Legg Calve Perthes Disease | 1 |
| Alfred I. duPont Hospital for Children - Nemours Deleware | B-cell Acute Lymphoblastic Leukemia | 1 |
| Alfred I. duPont Hospital for Children/Nemours | ADA SCID, Leaky SCID, Omenn Syndrome | 1 |
| Ascendis Investigational Site | Achondroplasia | 1 |
| AstraZeneca | Asthma | 1 |
| Brandywine Counseling & Community Services | Opioid Use Disorder | 1 |
| Christiana Care | Autoregulation, Encephalitis, Encephalopathy | 1 |
| ChristianaCare | Neonatal Opioid Withdrawal Syndrome | 1 |
| Delaware Hemophilia Treatment Center | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 1 |
| Family Practice Associates | Atherosclerotic Cardiovascular Disease, Obesity, Overweight | 1 |
Active & Upcoming Studies in Wilmington (2026)
Recruiting trials in Wilmington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (54 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Neurology & pain (8 active studies)
- Morphine or Ketamine for Analgesia · Phase 3 · Columbia University
- CoMind Early Feasibility Study · CoMind Technologies Limited
Cardiovascular (8 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
Pediatric (8 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
Diabetes & metabolic (5 active studies)
Vaccines (1 active study)
Common conditions studied in Wilmington
- Malignant Solid Neoplasm (6 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IV Pancreatic Cancer AJCC v8 (4 active studies). Pancreatic cancer studies investigate new chemotherapy backbones, targeted inhibitors, and combination approaches to improve historically poor outcomes.
- Achondroplasia (3 active studies). Recruiting Achondroplasia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Asthma (3 active studies). Asthma research tests biologic therapies targeting IL-4, IL-5, and TSLP pathways for moderate-to-severe and eosinophilic disease.
- B Acute Lymphoblastic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Wilmington
- Children's Oncology Group
- National Cancer Institute (NCI)
- Nemours Children's Clinic
- NRG Oncology
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in Delaware are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Delaware research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Wilmington. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Wilmington
Hipa.ai aggregates every recruiting study in Wilmington from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Wilmington?
There are approximately 161 recruiting clinical trials in Wilmington, Delaware listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Wilmington pay participants?
Most recruiting trials in Wilmington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Wilmington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Wilmington?
The most common conditions under active study in Wilmington include Malignant Solid Neoplasm (6), Stage IV Pancreatic Cancer AJCC v8 (4), Achondroplasia (3), Acute Myeloid Leukemia (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Wilmington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Wilmington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Wilmington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Wilmington?
Recruiting research sites in Wilmington include Christiana Care Health System-Wilmington Hospital, Alfred I duPont Hospital for Children, Nemours Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Wilmington right now?
The largest active categories in Wilmington are Cancer & tumors (54), Neurology & pain (8), Cardiovascular (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.